Tirschwell & Loewy Inc. Decreases Stake in Procter & Gamble Co (PG)

Tirschwell & Loewy Inc. cut its holdings in Procter & Gamble Co (NYSE:PG) by 44.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 5,082 shares of the company’s stock after selling 4,050 shares during the period. Tirschwell & Loewy Inc.’s holdings in Procter & Gamble were worth $423,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Personal Capital Advisors Corp raised its stake in Procter & Gamble by 15.4% in the 2nd quarter. Personal Capital Advisors Corp now owns 401,751 shares of the company’s stock worth $31,361,000 after acquiring an additional 53,508 shares during the last quarter. MUFG Securities EMEA plc purchased a new position in Procter & Gamble in the 2nd quarter worth $35,971,000. Aviva PLC raised its stake in Procter & Gamble by 3.4% in the 2nd quarter. Aviva PLC now owns 1,565,772 shares of the company’s stock worth $122,224,000 after acquiring an additional 52,069 shares during the last quarter. CFO4Life Group LLC raised its stake in Procter & Gamble by 709.0% in the 2nd quarter. CFO4Life Group LLC now owns 29,158 shares of the company’s stock worth $2,276,000 after acquiring an additional 25,554 shares during the last quarter. Finally, Crossvault Capital Management LLC purchased a new position in Procter & Gamble in the 2nd quarter worth $238,000. 61.36% of the stock is owned by institutional investors and hedge funds.

NYSE:PG opened at $98.48 on Tuesday. Procter & Gamble Co has a 52 week low of $70.73 and a 52 week high of $99.70. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.61 and a current ratio of 0.78. The stock has a market cap of $248.27 billion, a PE ratio of 23.34, a price-to-earnings-growth ratio of 3.19 and a beta of 0.38.

Procter & Gamble (NYSE:PG) last posted its earnings results on Wednesday, January 23rd. The company reported $1.25 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.04. Procter & Gamble had a return on equity of 21.41% and a net margin of 16.13%. The firm had revenue of $17.44 billion for the quarter, compared to analysts’ expectations of $17.16 billion. During the same period last year, the firm earned $1.19 EPS. The company’s quarterly revenue was up .2% on a year-over-year basis. As a group, analysts expect that Procter & Gamble Co will post 4.46 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, February 15th. Investors of record on Friday, January 18th were issued a $0.7172 dividend. This represents a $2.87 annualized dividend and a yield of 2.91%. The ex-dividend date was Thursday, January 17th. Procter & Gamble’s payout ratio is 68.01%.

In related news, Director Trian Fund Management, L.P. sold 1,208,754 shares of Procter & Gamble stock in a transaction dated Friday, February 15th. The stock was sold at an average price of $99.08, for a total value of $119,763,346.32. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Carolyn M. Tastad sold 19,791 shares of Procter & Gamble stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $92.71, for a total value of $1,834,823.61. Following the completion of the sale, the insider now owns 60,575 shares in the company, valued at $5,615,908.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 2,214,536 shares of company stock worth $219,175,393. 1.84% of the stock is currently owned by insiders.

Several equities research analysts have weighed in on the company. Wells Fargo & Co increased their price target on Procter & Gamble from $78.00 to $84.00 and gave the stock a “market perform” rating in a research report on Monday, October 22nd. They noted that the move was a valuation call. Barclays reaffirmed a “hold” rating and set a $94.00 price target on shares of Procter & Gamble in a research report on Friday, January 25th. Zacks Investment Research raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $102.00 price target on the stock in a research report on Monday, January 21st. Evercore ISI assumed coverage on Procter & Gamble in a research report on Thursday, January 10th. They set an “outperform” rating and a $105.00 price target on the stock. Finally, Bank of America raised Procter & Gamble from a “neutral” rating to a “buy” rating and set a $108.00 price target on the stock in a research report on Thursday, December 13th. Twelve investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $95.00.

ILLEGAL ACTIVITY NOTICE: “Tirschwell & Loewy Inc. Decreases Stake in Procter & Gamble Co (PG)” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are accessing this report on another website, it was stolen and reposted in violation of US & international copyright laws. The legal version of this report can be viewed at https://www.themarketsdaily.com/2019/02/19/tirschwell-loewy-inc-decreases-stake-in-procter-gamble-co-pg.html.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods to consumers in North America, Europe, the Asia Pacific, Greater China, Latin America, India, the Middle East, and Africa. The company operates in five segments: Beauty; Grooming; health Care; fabric & Home Care; and Baby, Feminine & Family Care.

Read More: Front-End Load

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Co (NYSE:PG).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.